Europe’s metabolic problem is broader than obesity
Metabolic health is often reduced to body weight. The data tell a wider story.
Blood pressure, waist circumference, blood glucose, triglycerides, and HDL cholesterol can begin moving in an unhealthy direction before someone meets the definition of obesity—or before several abnormalities cluster into metabolic syndrome. This makes the widest category important: how many people have at least one warning sign?
A Dutch population study reported that only 19% of adults had no cardiometabolic abnormalities. Put another way, 81% had at least one component: 30% had one, 21% had two, and the remainder had a larger cluster [1]. Studies using stricter definitions of “optimal metabolic health” in the United States found similarly small healthy minorities—12.2% in one analysis and 6.8% in another [2][3]. Norwegian population research also shows that strict metabolic health, defined using no abnormal metabolic-syndrome components, is uncommon and highly dependent on the definition used [4].
These studies are not directly interchangeable. They use different countries, age ranges, markers, and thresholds. But together they support a careful conclusion: around 8 in 10 adults in Western populations may show at least one metabolic warning sign.
The burden at a glance
From early warning signs to population-wide consequences
A widespread signal
Around 8 in 10
had at least one cardiometabolic abnormality
Dutch adult cohort; a Western-population signal, not an EU-wide estimate [1][2][3][4]
European prevalence
Related measures, each showing a burden affecting a substantial share of adults.
Almost 60%
had overweight or obesity
BMI of at least 25, including obesity
Adults in the WHO European Region; report published in 2022, based principally on 2016 estimates [5]
23%
had obesity
BMI of at least 30
EU adults; measured population studies, 2016 [6]
24.3%
had metabolic syndrome
A cluster of multiple metabolic risk markers
34,821 adults across ten European countries [8]
The consequences
Metabolic burden reaches beyond individual diagnoses.
583,000+
deaths and more than 14 million DALYs
Associated with high BMI in EU countries, 2019 [6]
€70 billion
in annual healthcare and productivity costs
Estimated cost of adult obesity in the EU, 2016 [6]
How to read the figures
The figures move from broad warning signs toward narrower clinical categories, but they do not form a strict funnel.
- At least one cardiometabolic abnormality means one or more measured markers crossed the study’s threshold.
- Overweight or obesity generally means a body mass index (BMI) of at least 25. This combined category includes everyone in the obesity category.
- Obesity generally means a BMI of at least 30.
- Metabolic syndrome means a defined cluster of several markers, commonly abdominal obesity, elevated triglycerides, low HDL cholesterol, elevated blood pressure, and elevated fasting glucose.
Someone can have metabolic abnormalities without obesity, or obesity without meeting the full criteria for metabolic syndrome. The estimates also come from different studies, so they should not be added together or treated as nested groups [6][8].
The important point is simpler: metabolic risk reaches far beyond the people who already have a diagnosis.
The burden reaches far beyond the scale
High BMI was associated with more than 583,000 deaths and more than 14 million disability-adjusted life years in EU countries in 2019 [6]. These are attribution estimates rather than death-certificate counts, but they show the scale of disease connected to excess weight across cardiovascular disease, diabetes, cancer, and other conditions.
The economic exposure is also substantial. The European Commission reports an estimated €70 billion per year in EU healthcare costs and lost productivity from adult obesity in 2016 [6]. OECD’s broader modelling estimates that obesity accounts for approximately 8% of total health expenditure and 3.3% of GDP across OECD countries [7].
Behind those totals are years lived with conditions that can affect energy, mobility, fertility, mental wellbeing, work, and everyday independence. Metabolic problems often reinforce one another: rising blood glucose, blood pressure, abdominal fat, and abnormal blood lipids can combine to increase long-term risk more than any one marker suggests on its own [5][6][7].
These figures are not live 2026 totals. They show that the burden was already structural years ago—and that the consequences are measured not only in healthcare spending, but in health and quality of life.
Medicines are changing treatment, not eliminating prevention
The treatment landscape has changed rapidly. GLP-1 receptor agonists and related medicines can produce clinically meaningful weight loss and improve some obesity-related outcomes for appropriately selected patients. Demand has risen quickly enough for European regulators to coordinate action on shortages and warn against inappropriate off-label use [10].
That progress matters. Obesity is a chronic disease, and effective treatment should not be framed as a failure of character. However, lifestyle intervention is still the primary care method and key to sustainable change when combined with medical intervention.
In addition, medication does not make population prevention obsolete. Europe still needs food environments that support healthier patterns, earlier identification of risk, access to dietitians and structured lifestyle care, and long-term clinical follow-up. Medicines are one part of that system—not a replacement for it [5][7][10].
Risk rises with age—and follows social conditions
Metabolic risk is not spread evenly.
Eurostat’s 2022 data show the combined share with overweight or obesity rising from 20.3% among people aged 16–24 to 63.6% among those aged 65–74 [9]. Ageing changes body composition and metabolic risk, but the steep gradient also reflects decades of accumulated exposure to food environments, inactivity, sleep disruption, stress, medication effects, and unequal access to preventive care.
Education and income matter too. European data consistently show higher rates of overweight and obesity in groups with less education, particularly among women [9]. That pattern argues against a simple story of individual willpower. Food price, working conditions, neighbourhood design, marketing, time, and access to healthcare all shape the choices available to people [5][7].
A useful public-health response therefore has to work at two levels: make healthier defaults easier across the population, and make effective individual support available without shame.
What earlier action can look like
The practical lesson is not that everyone needs to chase perfect numbers. It is that waiting for advanced disease can miss years in which risk is easier to address.
Know more than your weight
Weight can provide useful context, but it cannot show the whole metabolic picture. Depending on personal circumstances, appropriate screening may include:
- waist circumference,
- blood pressure,
- fasting glucose or HbA1c,
- triglycerides,
- and HDL cholesterol.
Which tests are appropriate—and how results should be interpreted—depends on age, symptoms, medical history, medications, pregnancy status, and other clinical context. A clinician should guide diagnosis and treatment.
Make repeatable changes
Nutrition support can still begin with ordinary, sustainable changes: more vegetables, legumes, fruit, whole grains, nuts, and other minimally processed staples; fewer sugary drinks and heavily processed defaults; and meal structures that remain workable on busy days. Sleep, activity, alcohol, stress, and smoking also belong in the metabolic-health picture. Simply taking the first step of logging your meals can be a strong start. Through awareness of your nutrition choices you can progress to making a sustainable change step-by-step. The most useful plan is usually the one that can survive ordinary life. Small changes repeated over months matter more than a perfect week followed by exhaustion.
Get support before complications appear
People do not need to wait for diabetes, cardiovascular disease, or severe obesity before asking for help. Primary care, dietitians, structured lifestyle programmes, psychological support, and—when clinically appropriate—medication can all play a role. Earlier support also creates more room to find an approach that fits a person’s health, culture, budget, and daily routine.
The point is not to turn every meal into a medical intervention. It is to make the healthy direction easier to repeat before warning signs become complications.
The clearest conclusion
Europe’s metabolic burden is not captured by one number.
The broadest evidence suggests that at least one warning sign is common across Western populations. Almost 60% of adults in the WHO European Region have overweight or obesity. Around one quarter meet measured obesity criteria in the best EU estimate, and around one quarter had metabolic syndrome in a large ten-country analysis [1][5][6][8].
The useful response is neither panic nor blame. It is earlier awareness, practical support, healthier environments, and sustained access to evidence-based nutrition and medical care.